• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Oncolytics Biotech Inc

+ Add to Watchlist

ONC:CN

1.4400 CAD 0.0100 0.69%

As of 15:59:54 ET on 09/12/2014.

Company Profile for Oncolytics Biotech Inc (ONC)

Oncolytics Biotech Inc. discovers and develops pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. The Company is focusing on the development of the reovirus known as REOLYSIN as a potential cancer therapeutic.

Contact Information

Oncolytics Biotech Inc

Suite 210
1167 Kensington Crescent NW
Calgary, AB T2N 1X7
Canada
Phone: 1-403-670-7377
Fax: 1-403-283-0858

Key Executives for Oncolytics Biotech Inc (ONC)

Bradley G Thompson "Brad"Chairman/President/CEOKirk LookChief Financial Officer
Matthew C Coffey "Matt"COO/Co-FounderAlan J TuchmanSenior VP:Clinical/Chief Medical Ofcr
George M GillSenior VP:Regulatory AffairsMary Ann DillahuntyVP:Intellectual Property
Jeremy GrushcowGeneral Counsel

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil